3:21
Doctor tells of fraud and dishonesty at drug giant Ranbaxy
Generic drug companies like Ranbaxy must prove their drugs have the same effect as brand-n...
published: 07 Nov 2013
Doctor tells of fraud and dishonesty at drug giant Ranbaxy
Doctor tells of fraud and dishonesty at drug giant Ranbaxy
Generic drug companies like Ranbaxy must prove their drugs have the same effect as brand-name medicines. But when Dr. Kathy Spreen was hired to help the company comply with FDA regulations, she became alarmed when she realized the company was faking its data. John Miller reports.- published: 07 Nov 2013
- views: 27
4:55
Dinesh Thakur on Ranbaxy US FDA case
Dinesh Thakur, former Ranbaxy director and the whistle in the case, speaks to Mint about t...
published: 22 May 2013
author: livemintvideos
Dinesh Thakur on Ranbaxy US FDA case
Dinesh Thakur on Ranbaxy US FDA case
Dinesh Thakur, former Ranbaxy director and the whistle in the case, speaks to Mint about the implications of the order for the Indian generic drug industry. ...- published: 22 May 2013
- views: 606
- author: livemintvideos
29:31
The Big Picture - Ranbaxy affair: Impact on Indian Pharma companies
Guests: P K Hota (Former Health Secretary, Govt of India) ; Dr. C M Gulati (Editor, MIMS) ...
published: 31 May 2013
author: Rajya Sabha TV
The Big Picture - Ranbaxy affair: Impact on Indian Pharma companies
The Big Picture - Ranbaxy affair: Impact on Indian Pharma companies
Guests: P K Hota (Former Health Secretary, Govt of India) ; Dr. C M Gulati (Editor, MIMS) ; Dr. Suresh Chandra Sharma (Professor and HOD, ENT, AIIMS) ; Dr. G...- published: 31 May 2013
- views: 453
- author: Rajya Sabha TV
4:13
Ranbaxy fined $ 500 mn for selling adulterated drugs
Generic drugmaker Ranbaxy has been fined $500 million by the US government after its subsi...
published: 14 May 2013
author: ibnlive
Ranbaxy fined $ 500 mn for selling adulterated drugs
Ranbaxy fined $ 500 mn for selling adulterated drugs
Generic drugmaker Ranbaxy has been fined $500 million by the US government after its subsidiary pleaded guilty to sale of adulterated drugs manufactured in I...- published: 14 May 2013
- views: 295
- author: ibnlive
2:46
Ranbaxy case: Should Indian patients worry over sub-standard drugs?
India exports drugs worth more than 15 billion dollars every year, a majority of which are...
published: 05 Jun 2013
author: ibnlive
Ranbaxy case: Should Indian patients worry over sub-standard drugs?
Ranbaxy case: Should Indian patients worry over sub-standard drugs?
India exports drugs worth more than 15 billion dollars every year, a majority of which are US-bound. Questions are being raised about the standards and quali...- published: 05 Jun 2013
- views: 80
- author: ibnlive
1:25
Apollo Pharmacy issues advisory against Ranbaxy drugs
Apollo Pharmacy on Friday issued a cautionary advisory against Ranbaxy drugs and temporari...
published: 07 Jun 2013
author: ibnlive
Apollo Pharmacy issues advisory against Ranbaxy drugs
Apollo Pharmacy issues advisory against Ranbaxy drugs
Apollo Pharmacy on Friday issued a cautionary advisory against Ranbaxy drugs and temporarily suspended their sale. Earlier, Mumbai's Jaslok Hospital had stop...- published: 07 Jun 2013
- views: 118
- author: ibnlive
10:11
Ranbaxy under fire: Will India's pharma industry be hit?
There is more trouble for Ranbaxy, this time from the European Union. The new headache for...
published: 04 Jun 2013
author: NDTV
Ranbaxy under fire: Will India's pharma industry be hit?
Ranbaxy under fire: Will India's pharma industry be hit?
There is more trouble for Ranbaxy, this time from the European Union. The new headache for India's largest pharmaceutical company comes as it battles a huge ...- published: 04 Jun 2013
- views: 408
- author: NDTV
0:53
Ranbaxy may touch Rs 530, BHEL looks strong: Chaturmohta
According to Ashish Chaturmohta of Fortune Equity Brokers, Ranbaxy Laboratories may touch ...
published: 26 Dec 2013
Ranbaxy may touch Rs 530, BHEL looks strong: Chaturmohta
Ranbaxy may touch Rs 530, BHEL looks strong: Chaturmohta
According to Ashish Chaturmohta of Fortune Equity Brokers, Ranbaxy Laboratories may touch Rs 530 as it has seen a very significant addition of open interest (OI). BHEL looks strong, he adds.- published: 26 Dec 2013
- views: 18
0:58
Ranbaxy, Lupin may add 8-10%: Ashish Chaturmohta
Ashish Chaturmohta of Fortune Equity Brokers feels that Ranbaxy Laboratories and Lupin are...
published: 26 Dec 2013
Ranbaxy, Lupin may add 8-10%: Ashish Chaturmohta
Ranbaxy, Lupin may add 8-10%: Ashish Chaturmohta
Ashish Chaturmohta of Fortune Equity Brokers feels that Ranbaxy Laboratories and Lupin are looking good for 8-10 percent upside from current levels.- published: 26 Dec 2013
- views: 15
5:34
Ranbaxy CEO says the pharma company's medicines have always been safe
Under attack for manufacturing spurious drugs, Ranbaxy CEO Arun Sawhney told CNN-IBN that ...
published: 06 Jun 2013
author: ibnlive
Ranbaxy CEO says the pharma company's medicines have always been safe
Ranbaxy CEO says the pharma company's medicines have always been safe
Under attack for manufacturing spurious drugs, Ranbaxy CEO Arun Sawhney told CNN-IBN that Ranbaxy medicines are completely safe and that his company has resu...- published: 06 Jun 2013
- views: 208
- author: ibnlive
2:28
Ranbaxy to launch Lipitor in US by November
Ranbaxy will launch the generic version of the world's top selling cholesterol-controlling...
published: 09 Sep 2011
author: ndtvprofit
Ranbaxy to launch Lipitor in US by November
Ranbaxy to launch Lipitor in US by November
Ranbaxy will launch the generic version of the world's top selling cholesterol-controlling drug Lipitor in the US markets in November. This opens up a big op...- published: 09 Sep 2011
- views: 665
- author: ndtvprofit
1:43
US FDA bans imports from Ranbaxy's Mohali plant
Read the full story at http://ibnlive.in.com/news/us-fda-bans-imports-from-ranbaxys-mohali...
published: 16 Sep 2013
US FDA bans imports from Ranbaxy's Mohali plant
US FDA bans imports from Ranbaxy's Mohali plant
Read the full story at http://ibnlive.in.com/news/us-fda-bans-imports-from-ranbaxys-mohali-plant/422383-7.html The US Food and Drug Administration has issued an import alert against drugs manufactured at Ranbaxy's Mohali plant in Punjab over quality concerns. This means Ranbaxy will not be able to ship drugs manufactured at the plant to the US until the ban is lifted. This is the third alert against Ranbaxy. Warnings have been earlier issued against its plants in Paonta and Dewas. Ranbaxy, however, said it has not received any such warning.- published: 16 Sep 2013
- views: 27
3:41
Adulterated drugs: Mumbai hospital stops Ranbaxy products
In more trouble for pharma giant Ranbaxy, one of Mumbai's top hospitals asked its consulta...
published: 05 Jun 2013
author: ibnlive
Adulterated drugs: Mumbai hospital stops Ranbaxy products
Adulterated drugs: Mumbai hospital stops Ranbaxy products
In more trouble for pharma giant Ranbaxy, one of Mumbai's top hospitals asked its consultants to stop buying its products over the adulterated drugs controve...- published: 05 Jun 2013
- views: 233
- author: ibnlive
2:02
Generic Lipitor Alternative Contain Glass Particles, Ranbaxy Plant Closed After FDA Investigation
FDA is monitoring recall after glass particles were found in bottles of a generic version ...
published: 30 Nov 2012
author: ABCNews
Generic Lipitor Alternative Contain Glass Particles, Ranbaxy Plant Closed After FDA Investigation
Generic Lipitor Alternative Contain Glass Particles, Ranbaxy Plant Closed After FDA Investigation
FDA is monitoring recall after glass particles were found in bottles of a generic version of Lipitor. For more on this story, click here: http://abcnews.go.c...- published: 30 Nov 2012
- views: 752
- author: ABCNews
Youtube results:
6:46
Ranbaxy falls over 30 pct after FDA import alert
Ranbaxy falls over 30 pct after FDA import alert
For more information:
Subscribe - www.y...
published: 16 Sep 2013
Ranbaxy falls over 30 pct after FDA import alert
Ranbaxy falls over 30 pct after FDA import alert
Ranbaxy falls over 30 pct after FDA import alert For more information: Subscribe - www.youtube.com/etnow to get latest business news,analysis and updates. Follow - www.dailymotion.com/etnow to get latest video updates.- published: 16 Sep 2013
- views: 1
5:36
The Ranbaxy Affair: Is the drug giant paying for its fraudulent actions?
ACSH has an exclusive interview with chemist and medicinal blogger Derek Lowe ("In the Pip...
published: 18 Jun 2013
author: ACSHonTV
The Ranbaxy Affair: Is the drug giant paying for its fraudulent actions?
The Ranbaxy Affair: Is the drug giant paying for its fraudulent actions?
ACSH has an exclusive interview with chemist and medicinal blogger Derek Lowe ("In the Pipeline"). Lowe talks about Ranbaxy Pharmaceuticals' ploy to delibera...- published: 18 Jun 2013
- views: 177
- author: ACSHonTV
22:28
Racist Ranbaxy - Wide Angle- 10Tv
For more content go to http://10tv.in/wide-angle/Racist-Ranbaxy http://www.10tv.in Ranbaxy...
published: 29 May 2013
author: 10TVNewsChannel
Racist Ranbaxy - Wide Angle- 10Tv
Racist Ranbaxy - Wide Angle- 10Tv
For more content go to http://10tv.in/wide-angle/Racist-Ranbaxy http://www.10tv.in Ranbaxy has shown its racist side.When it received complaints on the subst...- published: 29 May 2013
- views: 126
- author: 10TVNewsChannel
10:43
Ranbaxy Global Consumer Healthcare & Aanjaneya Lifecare Declared Winners
4th Annual Pharmaceutical Leadership Summit & Awards 2011 ( www.pharmasummit,in ) organize...
published: 17 Dec 2011
author: SATYA BRAHMA
Ranbaxy Global Consumer Healthcare & Aanjaneya Lifecare Declared Winners
Ranbaxy Global Consumer Healthcare & Aanjaneya Lifecare Declared Winners
4th Annual Pharmaceutical Leadership Summit & Awards 2011 ( www.pharmasummit,in ) organized by India's leading bi-monthly Pharma Magazine ( www.pharmaleaders...- published: 17 Dec 2011
- views: 873
- author: SATYA BRAHMA